FDA Inspection 1274311 — Dr. Pablo Forte Soto MD, MSc, DPhil

Dr. Pablo Forte Soto MD, MSc, DPhil — FEI 3033711412

The FDA completed an inspection of Dr. Pablo Forte Soto MD, MSc, DPhil on May 2, 2025 in Harrow. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
May 2, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Harrow (United Kingdom)

Additional details

Clinical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.